Insperity and Corcept Executives Increase Stock Holdings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2026
0mins
Source: NASDAQ.COM
- Insperity CEO Purchase: Insperity's CEO Paul J. Sarvadi bought 201,987 shares of NSP at $23.21 each on Thursday, totaling an investment of $4.69 million, indicating strong confidence in the company's future prospects.
- Positive Stock Performance: As of Friday, Insperity's stock rose approximately 10.8%, with Sarvadi's investment currently yielding about 9.4% profit, reflecting a favorable market response to the stock.
- Corcept Executive Acquisition: G. Leonard Baker Jr. purchased 100,000 shares of Corcept Therapeutics at $33.14 each on Tuesday, amounting to $3.31 million, marking his first purchase in the past year and signaling optimism about the company's outlook.
- Market Reaction: As of Friday, Corcept Therapeutics' stock increased by about 4.7%, with Baker Jr.'s investment also achieving approximately 9.4% profit, demonstrating market recognition of the stock.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NSP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NSP
Wall Street analysts forecast NSP stock price to rise
2 Analyst Rating
1 Buy
0 Hold
1 Sell
Hold
Current: 32.950
Low
62.00
Averages
62.00
High
62.00
Current: 32.950
Low
62.00
Averages
62.00
High
62.00
About NSP
Insperity, Inc. provides an array of human resources (HR) and business solutions. The Company serves small and medium-sized businesses by providing its PEO HR solutions, which encompass a range of services. Its professional employer organization (PEO) HR solutions, offers payroll and benefits administration, general HR advice, health and workers compensation insurance programs, 401(k) retirement plan sponsored by the United States, employer liability management, assistance with government compliance and personnel records management. It also offers other business performance solutions, including talent acquisition services, retirement services, insurance services, contractor management, and perks+. Its talent acquisition services offer direct hire placement on an as-needed basis and provides outsourced support for individual requisitions or large-scale hiring projects. Its Retirement Services offer comprehensive 401(k) retirement plan recordkeeping and administrative services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Sentiment Boost: The Dow Jones Industrial Average surged over 300 points, briefly exceeding 50,700, reflecting improved market sentiment that drove multiple stocks higher, indicating increased investor confidence in economic recovery.
- Rising Demand for Business Services: With falling Treasury yields reducing financing costs for mid-sized clients, companies like Insperity and Avnet are seeing faster contract approvals, which is expected to drive revenue growth over the coming quarters.
- Geopolitical Risk Easing: Progress on the Iran peace deal has removed significant geopolitical overhangs, encouraging corporations to release project backlogs that had been paused due to conflict, further boosting revenue recognition for business services firms.
- Strong Performance of Viasat: Viasat's stock rose by 3.9%, and it has increased by 97.3% year-to-date, nearing its 52-week high, reflecting market optimism about its future growth despite volatility and macroeconomic challenges.
See More
- Quarterly Cash Dividend: Insperity's board has declared a cash dividend of $0.60 per share, payable on June 18, 2026, reflecting the company's commitment to shareholder returns and enhancing investor confidence.
- Record Date for Shareholders: The record date for this dividend is set for June 4, 2026, ensuring that all eligible shareholders can benefit from this distribution, thereby strengthening the relationship between the company and its investors.
- Financial Performance: Insperity anticipates revenues of $6.8 billion for 2025, indicating robust business performance and growth potential in the U.S. market, which solidifies its position as a leading HR solutions provider.
- Service and Technology Integration: By combining premium HR services with technology, Insperity offers comprehensive HR solutions that help businesses reduce liabilities and enhance performance, further driving the company's competitive advantage in the industry.
See More
- Earnings Decline: Insperity reported adjusted earnings per share of $1.31 for Q1, exceeding analyst expectations; however, the company's lowered full-year guidance led to a 16.5% drop in stock price during the morning session.
- Uncertain Outlook: The company forecasts adjusted earnings for Q2 between $0.02 and $0.50 per share, significantly below the analyst consensus of $0.47, indicating uncertainty regarding future profitability.
- Rising Costs: Insperity attributed a 70% year-over-year decline in adjusted earnings per share to increased pharmacy expenses and a higher frequency of large insurance claims, which also caused gross profit to fall by 14% compared to the same quarter last year.
- Stock Performance: Insperity's stock has declined 21.6% since the beginning of the year, trading at $30.27 per share, which is 57.8% below its 52-week high of $71.75, reflecting the market's pessimistic outlook on the company's future prospects.
See More
- Revenue Meets Expectations: Insperity reported Q1 2026 revenue of $1.90 billion, reflecting a 1.7% year-over-year growth that aligns with Wall Street forecasts, indicating stability in the company's market position.
- Earnings Beat Estimates: The non-GAAP earnings per share of $1.31 exceeded analyst expectations of $1.23 by 6.2%, showcasing improvements in cost control and operational efficiency.
- Adjusted Full-Year Guidance: Management lowered the full-year adjusted EPS guidance to $2.10, a 4.8% decrease from previous estimates, reflecting a cautious outlook on growth amid weak sentiment among small business clients.
- New Product Growth Drivers: Insperity is launching HRScale and AI-driven services, which, despite short-term client growth pressures, are expected to restore growth momentum in the mid-market segment over the medium term.
See More
- Financial Performance Overview: Insperity reported Q1 2026 adjusted EPS of $1.31 and adjusted EBITDA of $103 million, while the average number of paid worksite employees was 303,049, at the low end of the forecast range, indicating overall business growth challenges.
- Margin Recovery Progress: Although total gross profit decreased by 3% to $302 million, the benefit cost per employee improved from a 9% increase last year to 5%, demonstrating the company's effectiveness in cost control measures.
- Contract Change Impact: The change in the UnitedHealthcare contract is expected to improve quarterly profitability patterns by lowering the cost cap per member to $500,000, which will help smooth future earnings fluctuations and enhance financial stability.
- Future Outlook Adjustment: While the full-year adjusted EBITDA forecast remains at $170 million to $230 million, the expected range for worksite employees has been lowered to 303,000 to 307,000, reflecting management's cautious stance on small business economic sentiment.
See More
- Earnings Beat: Insperity reported a Q1 non-GAAP EPS of $1.31, exceeding expectations by $0.08, which reflects the company's resilience amid economic uncertainties and boosts investor confidence.
- Revenue Growth: The company achieved $2.08 billion in revenue for Q1, marking a 2.5% year-over-year increase and surpassing market expectations by $190 million, indicating the effectiveness of its business model in the current economic climate.
- 2026 Guidance Update: Insperity updated its financial guidance for 2026, projecting adjusted EPS for Q2 to range between $0.02 and $0.50, reflecting a cautiously optimistic outlook for future growth.
- EBITDA Expectations: The adjusted EBITDA for 2026 is expected to be between $170 million and $230 million, despite a 44% year-over-year decrease, showcasing the company's potential in cost control and profitability.
See More










